The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dose adjustment of axitinib based on AUC in sunitinib-pretreated metastatic renal cell carcinoma.
 
Yuji Miura
Honoraria - Kyowa Hakko Kirin; Novartis
 
Chiyo K. Imamura
Employment - Allergan (I); Gilead Sciences (I)
 
Keita Uchino
No Relationships to Disclose
 
Takeshi Kishida
No Relationships to Disclose
 
Nobuaki Matsubara
Speakers' Bureau - Sanofi
Research Funding - Bayer (Inst); Janssen (Inst)
 
Toshiaki Shinojima
No Relationships to Disclose
 
Keiichi Kondo
No Relationships to Disclose
 
Fumiya Hongo
Speakers' Bureau - Bayer; Pfizer
Research Funding - Pfizer (Inst)
 
Kenichi Yoshimura
No Relationships to Disclose
 
Yusuke Tanigawara
Honoraria - Taiho Pharmaceutical
Consulting or Advisory Role - Fujimoto; Meiji Seika Kaisha
 
Toshimi Takano
Honoraria - Daiichi Sankyo; Kyowa Hakko Kirin
Research Funding - Chugai Pharma (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)